April
Value Frameworks as a Predictor of HTA Success
How value frameworks shape clinical benefit assessment, uncertainty and reimbursement outcomes
How do value frameworks influence HTA decisions? In this 60-minute masterclass, LSE Professor Panos Kanavos explores how clinical benefit assessment tools, uncertainty management and decision modifiers shape reimbursement outcomes across global markets.
May
Germany, Austria and Switzerland – Market Access Made Simple
Clear insight into payer pathways and decision-making across Germany, Austria and Switzerland
Join global market access experts Allister Upton and Andrew Mumford for a practical guide to navigating payer pathways across the region. Gain clarity on how decisions are made, who holds influence and what strategies can speed patient access to innovative medicines.